90 related articles for article (PubMed ID: 9579570)
1. Trends in seroprevalence of human papillomavirus type 16 among pregnant women in Stockholm, Sweden, during 1969-1989.
af Geijersstam V; Wang Z; Lewensohn-Fuchs I; Eklund C; Schiller JT; Forsgren M; Dillner J
Int J Cancer; 1998 May; 76(3):341-4. PubMed ID: 9579570
[TBL] [Abstract][Full Text] [Related]
2. Seroprevalence of human papillomavirus type 16 in pregnant women.
Hagensee ME; Slavinsky J; Gaffga CM; Suros J; Kissinger P; Martin DH
Obstet Gynecol; 1999 Nov; 94(5 Pt 1):653-8. PubMed ID: 10546705
[TBL] [Abstract][Full Text] [Related]
3. A survey of seroprevalence of human papillomavirus types 16, 18 and 33 among children.
af Geijersstam V; Eklund C; Wang Z; Sapp M; Schiller JT; Dillner J; Dillner L
Int J Cancer; 1999 Feb; 80(4):489-93. PubMed ID: 9935145
[TBL] [Abstract][Full Text] [Related]
4. Time trends in incidence and prevalence of human papillomavirus type 6, 11 and 16 infections in Finland.
Laukkanen P; Koskela P; Pukkala E; Dillner J; Läärä E; Knekt P; Lehtinen M
J Gen Virol; 2003 Aug; 84(Pt 8):2105-2109. PubMed ID: 12867641
[TBL] [Abstract][Full Text] [Related]
5. Latent human papillomavirus infection in pregnant women at term: a case-control study.
Tenti P; Zappatore R; Migliora P; Spinillo A; Maccarini U; De Benedittis M; Vesentini N; Marchitelli G; Silini E; Carnevali L
J Infect Dis; 1997 Jul; 176(1):277-80. PubMed ID: 9207382
[TBL] [Abstract][Full Text] [Related]
6. No excess risk of cervical carcinoma among women seropositive for both HPV16 and HPV6/11.
Luostarinen T; af Geijersstam V; Bjørge T; Eklund C; Hakama M; Hakulinen T; Jellum E; Koskela P; Paavonen J; Pukkala E; Schiller JT; Thoresen S; Youngman LD; Dillner J; Lehtinen M
Int J Cancer; 1999 Mar; 80(6):818-22. PubMed ID: 10074912
[TBL] [Abstract][Full Text] [Related]
7. Correlates of the spread of human papillomavirus infection.
Silins I; Kallings I; Dillner J
Cancer Epidemiol Biomarkers Prev; 2000 Sep; 9(9):953-9. PubMed ID: 11008914
[TBL] [Abstract][Full Text] [Related]
8. [Human papilloma virus infection in pregnant women with normal pap-smears, HPV oncogenity and risk factors].
Nowak Z; Karowicz-Bilińska A
Ginekol Pol; 2007 Sep; 78(9):678-84. PubMed ID: 18159820
[TBL] [Abstract][Full Text] [Related]
9. [Risk factors and frequency of occurrence of HPV DNA of high oncogenic types in paraepidermal epithelium cells of the uterine cervix, in the trophoblast, and in the peripheral blood of pregnant patients].
Tarka A; Szczepańska M; Raczyńska D; Pruski D; Kedzia W; Opala T
Ginekol Pol; 2008 Dec; 79(12):871-6. PubMed ID: 19175046
[TBL] [Abstract][Full Text] [Related]
10. Prevalence of human papillomavirus and herpes simplex virus in amniotic fluid from pregnant women of Eastern Poland.
Skoczyński M; Krzyżanowski AR; Goździcka-Józefiak A; Kwaśniewska A
Postepy Hig Med Dosw (Online); 2015 Dec; 69():1349-52. PubMed ID: 26671925
[TBL] [Abstract][Full Text] [Related]
11. Prevalence of human papillomavirus infection in pregnant versus non-pregnant women in Brazil.
Salcedo MM; Damin AP; Agnes G; Pessini SA; Beitune PE; Alexandre CO; Schmeler KM; da Silveira GP
Arch Gynecol Obstet; 2015 Dec; 292(6):1273-8. PubMed ID: 25990479
[TBL] [Abstract][Full Text] [Related]
12. Decreasing prevalence of herpes simplex virus-2 antibodies in selected groups of women in Sweden.
Berntsson M; Tunbäck P; Ellström A; Krantz I; Löwhagen GB
Acta Derm Venereol; 2009 Nov; 89(6):623-6. PubMed ID: 19997695
[TBL] [Abstract][Full Text] [Related]
13. Seroprevalence of HPV vaccine types 6, 11, 16 and 18 in HIV-infected and uninfected women from Brazil.
Nicol AF; Grinsztejn B; Friedman RK; Veloso VG; Cunha CB; Georg I; Pilotto JH; Moreira RI; Castro CA; Silver B; Viscidi RP
J Clin Virol; 2013 Jun; 57(2):147-51. PubMed ID: 23490398
[TBL] [Abstract][Full Text] [Related]
14. [Human papilloma virus (HPV) infections of the uterine cervix, vagina and vulva in women of childbearing age].
Basta A; Strama M; Pityński K; Kielar B; Gudynudis E
Ginekol Pol; 1994 Oct; 65(10):563-9. PubMed ID: 7729716
[TBL] [Abstract][Full Text] [Related]
15. [Evaluation of frequency human papillomavirus infections during pregnancy].
Szepietowska M; Słodziński H; Polz-Dacewicz M; Oleszczuk J
Ginekol Pol; 2002 Aug; 73(8):662-5. PubMed ID: 12369291
[TBL] [Abstract][Full Text] [Related]
16. Human papillomavirus infection in pregnant women.
Domža G; Gudlevičienė Z; Didžiapetrienė J; Valuckas KP; Kazbarienė B; Drąsutienė G
Arch Gynecol Obstet; 2011 Nov; 284(5):1105-12. PubMed ID: 21170544
[TBL] [Abstract][Full Text] [Related]
17. The association between pregnancy and human papilloma virus prevalence.
Smith EM; Johnson SR; Jiang D; Zaleski S; Lynch CF; Brundage S; Anderson RD; Turek LP
Cancer Detect Prev; 1991; 15(5):397-402. PubMed ID: 1661203
[TBL] [Abstract][Full Text] [Related]
18. High-throughput monitoring of human papillomavirus type distribution.
Söderlund-Strand A; Dillner J
Cancer Epidemiol Biomarkers Prev; 2013 Feb; 22(2):242-50. PubMed ID: 23221127
[TBL] [Abstract][Full Text] [Related]
19. Seroprevalence of herpes simplex virus types 1 and 2 in pregnant women in the United States.
Xu F; Markowitz LE; Gottlieb SL; Berman SM
Am J Obstet Gynecol; 2007 Jan; 196(1):43.e1-6. PubMed ID: 17240228
[TBL] [Abstract][Full Text] [Related]
20. High-risk human papillomavirus clearance in pregnant women: trends for lower clearance during pregnancy with a catch-up postpartum.
Nobbenhuis MA; Helmerhorst TJ; van den Brule AJ; Rozendaal L; Bezemer PD; Voorhorst FJ; Meijer CJ
Br J Cancer; 2002 Jul; 87(1):75-80. PubMed ID: 12085260
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
